shRNA-mediated MerTK knockdown or a series of MerTK-selective small molecular inhibitors, such as UNC1062, UNC569, and UNC2025, reduces activation of downstream signaling, inhibits proliferation and invasion, and promotes apoptosis in tumor cells [12, 14, 20–23]. Here, MERTK is linked to neoplasm.